PTAB
IPR2017-01526
Mylan Pharmaceuticals Inc v. Sanofi Aventis Deutschland GmbH
General
Filed
06/05/17
Institution12/13/17
FWD--
Close12/12/18
StatusFinal Written Decision
OutcomeUnpatentable
USPTOIPR2017-01526
Appeals
Petitioner
Attorney
Name | Ratings |
---|---|
L5 A | |
L5 A | |
L5 A | |
L5 A | |
L5 A | |
L5 A | |
L5 A |
No Attorneys
Respondent